Strand Life Sciences

Strand Life Sciences, formerly Strand Genomics, is an Indian in silico technology company, based in Bangalore. Strand focuses in data mining, predictive modeling, computational chemistry, software engineering, bioinformatics, and research biology to develop software and services for life sciences research. Strand also offers custom solutions based on its intellectual property.[1] In 2021, Reliance Industries' subsidiary Reliance Strategic Business Ventures acquired a controlling stake in Strand Life Sciences.[2]

Strand Life Sciences Pvt. Ltd.
TypePrivate
IndustrySoftware
Life Sciences
Healthcare
Founded2000
HeadquartersBangalore, Karnataka, India
Key people
Ramesh Hariharan (CEO)
Anand Janakiraman (President RiX)
Rohan Pais (COO)
Vamsi Veermachaneni (CSO)
ProductsStrandAdvantage
Strand NGS
Heptox
Avadis
ParentReliance Strategic Business Ventures
Websitewww.strandls.com

History

Strand Life Sciences was founded in October 2000 by Professors Vijay Chandru, Ramesh Hariharan, Swami Manohar, and V. Vinay. It was registered as Strand Genomics, but was later renamed to Strand Life Sciences as it dealt with various other aspects of life sciences. In August 2007, Strand and Agilent Technologies, Inc. entered an agreement in which Strand develops and supports Agilent's GeneSpring[3] software which Agilent obtained through Silicon Genetics acquisition in August 2004.[4] In October 2010, Strand and Agilent renewed the agreement[5] for Strand to expand the scope of Agilent's GeneSpring across multiple life sciences disciplines.

Software
  • Strand NGS (formerly Avadis NGS) is a software platform for next-generation sequencing data analysis.
  • GeneSpring GX (version 9.0.0 onwards), GeneSpring Workgroup (version 7.0.0 onwards), and Mass Profiler Pro are developed by Strand's R&D division in Bangalore.
  • Avadis is a data mining and visualization platform.
  • Sarchitect is a platform for modeling and predicting drug-relevant properties of molecules in silico.
  • ArrayAssist was developed for Stratagene, Inc., based on the Avadis platform. The production was stopped after Stratagene was acquired by Agilent Technologies, Inc. in 2007.

References
  1. http://www.biodevicesbiz.com/newsArticle.asp?nId=84896&cId=275
  2. "RIL's arm buys controlling stake in Strand Life Sciences". The Economic Times. Retrieved 13 October 2022.
  3. "Agilent - Agilent Technologies and Strand Life Sciences Announce GeneSpring Development Agreement". agilent.com. 5 January 2017. Retrieved 22 February 2017.
  4. "Agilent Technologies to Acquire Silicon Genetics, Leading Provider of Life Science Informatics". biodevicesbiz.com. Retrieved 22 February 2017.
  5. "Agilent - Agilent Technologies and Strand Team Up to Advance Integrated Biology Software Systems". agilent.com. 4 October 2010. Retrieved 22 February 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.